Advertisement

Table of Contents

November 12, 2015; 126 (20)

INSIDE BLOOD COMMENTARIES

REVIEW ARTICLE

HOW I TREAT

CLINICAL TRIALS AND OBSERVATIONS

  • Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma
    Jatin J. Shah, Edward A. Stadtmauer, Rafat Abonour, Adam D. Cohen, William I. Bensinger, Cristina Gasparetto, Jonathan L. Kaufman, Suzanne Lentzsch, Dan T. Vogl, Christina L. Gomes, Natalia Pascucci, David D. Smith, Robert Z. Orlowski and Brian G. M. Durie

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

  • High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia
    Antonio R. Lucena-Araujo, Haesook T. Kim, Carolina Thomé, Rafael H. Jacomo, Raul A. Melo, Rosane Bittencourt, Ricardo Pasquini, Katia Pagnano, Ana Beatriz F. Glória, Maria de Lourdes Chauffaille, Melina Athayde, Carlos S. Chiattone, Ingrid Mito, Rodrigo Bendlin, Carmino Souza, Cristina Bortolheiro, Juan L. Coelho-Silva, Stanley L. Schrier, Martin S. Tallman, David Grimwade, Arnold Ganser, Nancy Berliner, Raul C. Ribeiro, Francesco Lo-Coco, Bob Löwenberg, Miguel A. Sanz and Eduardo M. Rego

PLATELETS AND THROMBOPOIESIS

  • The ABCC4 membrane transporter modulates platelet aggregation
    Satish B. Cheepala, Aaron Pitre, Yu Fukuda, Kazumasa Takenaka, Yuanyuan Zhang, Yao Wang, Sharon Frase, Tamara Pestina, T. Kent Gartner, Carl Jackson and John D. Schuetz

RED CELLS, IRON, AND ERYTHROPOIESIS

THROMBOSIS AND HEMOSTASIS

BLOOD WORK

CORRESPONDENCE